£210 million to tackle deadly antimicrobial resistance

Up to £210 million of funding to partner with countries across Asia and Africa to tackle antimicrobial resistance (AMR) and reduce the threat posed to the UK.

State of the art laboratories, cutting-edge disease surveillance systems, and a bigger global workforce to tackle deadly antimicrobial resistance (AMR) will be backed by up to £210 million of funding, the government has announced today (Wednesday 16 August).

The funding – from the government’s UK aid budget – will support the Fleming Fund’s activities to tackle AMR in countries across Asia and Africa over the next 3 years, helping to reduce the threat it poses to the UK and globally.